GPR25
gene geneOn this page
Summary
GPR25 (G protein-coupled receptor 25, HGNC:4480) is a protein-coding gene on chromosome 1q32.1, encoding C-X-C chemokine receptor GPR25 (O00155). Receptor for the C-X-C chemokine CXCL17, which plays a key role in lymphocyte homing.
This gene is intronless and encodes a member of the G-protein coupled receptor 1 family. G-protein coupled receptors are membrane proteins which activate signaling cascades as a response to extracellular stress. This gene has been linked to arterial stiffness.
Source: NCBI Gene 2848 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 45 total
- Druggable target: yes
- MANE Select transcript:
NM_005298
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:4480 |
| Approved symbol | GPR25 |
| Name | G protein-coupled receptor 25 |
| Location | 1q32.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000170128 |
| Ensembl biotype | protein_coding |
| OMIM | 602174 |
| Entrez | 2848 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000304244
RefSeq mRNA: 1 — MANE Select: NM_005298
NM_005298
CCDS: CCDS1405
Canonical transcript exons
ENST00000304244 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001159564 | 200872981 | 200874178 |
Expression profiles
Bgee: expression breadth broad, 57 present calls, max score 85.33.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2040 / max 35.6376, expressed in 58 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 7663 | 0.2040 | 58 |
Top tissues by expression
226 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.33 | gold quality |
| granulocyte | CL:0000094 | 73.36 | gold quality |
| bone marrow cell | CL:0002092 | 58.24 | gold quality |
| blood | UBERON:0000178 | 56.86 | gold quality |
| vermiform appendix | UBERON:0001154 | 51.53 | gold quality |
| caecum | UBERON:0001153 | 50.09 | gold quality |
| right uterine tube | UBERON:0001302 | 49.62 | gold quality |
| blood vessel layer | UBERON:0004797 | 49.29 | gold quality |
| skin of hip | UBERON:0001554 | 49.27 | silver quality |
| body of stomach | UBERON:0001161 | 49.19 | gold quality |
| spleen | UBERON:0002106 | 49.03 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 48.95 | gold quality |
| choroid plexus epithelium | UBERON:0003911 | 48.89 | gold quality |
| fundus of stomach | UBERON:0001160 | 47.30 | gold quality |
| periodontal ligament | UBERON:0008266 | 47.14 | gold quality |
| stomach | UBERON:0000945 | 46.93 | gold quality |
| renal glomerulus | UBERON:0000074 | 46.86 | gold quality |
| metanephric glomerulus | UBERON:0004736 | 46.77 | gold quality |
| nephron tubule | UBERON:0001231 | 46.71 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 45.40 | silver quality |
| dorsal motor nucleus of vagus nerve | UBERON:0002870 | 45.35 | gold quality |
| inferior olivary complex | UBERON:0002127 | 45.14 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 44.87 | gold quality |
| cranial nerve II | UBERON:0000941 | 43.62 | silver quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| bone marrow | UBERON:0002371 | 43.33 | gold quality |
| amniotic fluid | UBERON:0000173 | 43.00 | gold quality |
| esophagus mucosa | UBERON:0002469 | 42.96 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 42.51 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.86 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- GPR-25 is homologous to receptors involved in blood pressure regulation. (PMID:17386346)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | gpr25 | ENSDARG00000057112 |
| mus_musculus | Gpr25 | ENSMUSG00000052759 |
| rattus_norvegicus | Gpr25 | ENSRNOG00000008603 |
Paralogs (7): BDKRB1 (ENSG00000100739), APLNR (ENSG00000134817), AGTR1 (ENSG00000144891), GPR15 (ENSG00000154165), BDKRB2 (ENSG00000168398), RXFP4 (ENSG00000173080), AGTR2 (ENSG00000180772)
Protein
Protein identifiers
C-X-C chemokine receptor GPR25 — O00155 (reviewed: O00155)
Alternative names: G-protein coupled receptor 25
All UniProt accessions (1): O00155
UniProt curated annotations — full annotation on UniProt →
Function. Receptor for the C-X-C chemokine CXCL17, which plays a key role in lymphocyte homing. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of downstream effectors, such as RhoA pathway. Activation by CXCL17 on lymphocytes activates the RhoA pathway, which regulates cytoskeletal dynamics and integrins, mediating lymphocyte recruitment into the respiratory, upper gastrointestinal, biliary and genito-urinary tracts.
Subcellular location. Cell membrane.
Tissue specificity. Present on activated B- and T-cells.
Induction. Induced on innate lymphocytes before emigration to the periphery.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_005289* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR050119 | CCR1-9-like | Family |
Pfam: PF00001
UniProt features (19 total): topological domain 8, transmembrane region 7, mutagenesis site 2, chain 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O00155-F1 | 82.48 | 0.59 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 112–191
Mutagenesis-validated functional residues (2):
| Position | Phenotype |
|---|---|
| 95 | abolished ability to be activated by cxcl17. |
| 178 | abolished ability to be activated by cxcl17. |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-418555 | G alpha (s) signalling events |
MSigDB gene sets: 73 (showing top):
GOBP_CELL_CHEMOTAXIS, GOBP_RESPONSE_TO_PEPTIDE, GOBP_LEUKOCYTE_CHEMOTAXIS, GOBP_TAXIS, GOBP_LEUKOCYTE_MIGRATION, GOBP_LYMPHOCYTE_CHEMOTAXIS, GOBP_LYMPHOCYTE_MIGRATION, NERF_Q2, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_CHEMOATTRACTANT_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, MARTENS_TRETINOIN_RESPONSE_UP, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_MONONUCLEAR_CELL_MIGRATION, GOBP_RESPONSE_TO_CHEMOKINE
GO Biological Process (6): G protein-coupled receptor signaling pathway (GO:0007186), leukocyte chemotaxis (GO:0030595), lymphocyte chemotaxis (GO:0048247), chemokine-mediated signaling pathway (GO:0070098), lymphocyte migration into lymphoid organs (GO:0097021), signal transduction (GO:0007165)
GO Molecular Function (3): G protein-coupled receptor activity (GO:0004930), C-X-C chemokine receptor activity (GO:0016494), protein binding (GO:0005515)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| GPCR downstream signalling | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| lymphocyte migration | 2 |
| G protein-coupled receptor signaling pathway | 2 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| leukocyte migration | 1 |
| cell chemotaxis | 1 |
| leukocyte chemotaxis | 1 |
| cytokine-mediated signaling pathway | 1 |
| cellular response to chemokine | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| transmembrane signaling receptor activity | 1 |
| chemokine receptor activity | 1 |
| C-X-C chemokine binding | 1 |
| binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
320 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GPR25 | GPR27 | Q9NS67 | 512 |
| GPR25 | OR7C2 | O60412 | 511 |
| GPR25 | GPR62 | Q9BZJ7 | 509 |
| GPR25 | TCTA | P57738 | 508 |
| GPR25 | OR5C1 | Q8NGR4 | 460 |
| GPR25 | KIF21B | O75037 | 453 |
| GPR25 | GPR162 | Q16538 | 436 |
| GPR25 | INAVA | Q3KP66 | 435 |
| GPR25 | GPR52 | Q9Y2T5 | 422 |
| GPR25 | POLR3A | O14802 | 420 |
| GPR25 | BLOC1S3 | Q6QNY0 | 420 |
| GPR25 | PRSS54 | Q6PEW0 | 414 |
| GPR25 | GPR176 | Q14439 | 409 |
| GPR25 | GPR150 | Q8NGU9 | 407 |
| GPR25 | PNPT1 | Q8TCS8 | 400 |
IntAct
112 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CREB3L1 | GPR25 | psi-mi:“MI:0915”(physical association) | 0.780 |
| GPR25 | CREB3L1 | psi-mi:“MI:0915”(physical association) | 0.780 |
| GPR25 | KASH5 | psi-mi:“MI:0915”(physical association) | 0.720 |
| GGT7 | GPR25 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KASH5 | GPR25 | psi-mi:“MI:0915”(physical association) | 0.720 |
| GPR25 | GGT7 | psi-mi:“MI:0915”(physical association) | 0.720 |
| GPR25 | FATE1 | psi-mi:“MI:0915”(physical association) | 0.700 |
| FATE1 | GPR25 | psi-mi:“MI:0915”(physical association) | 0.700 |
| GPR25 | VAPB | psi-mi:“MI:0915”(physical association) | 0.560 |
| NAALADL2 | GPR25 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PNMA1 | GPR25 | psi-mi:“MI:0915”(physical association) | 0.560 |
| VAPB | GPR25 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GPR25 | NAALADL2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GPR25 | PNMA1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GPR25 | ATP6V0E1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GPR25 | SHISAL1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GPR25 | SLC35E3 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (36): GPR25 (Two-hybrid), VAPB (Two-hybrid), PNMA1 (Two-hybrid), FATE1 (Two-hybrid), CREB3L1 (Two-hybrid), CCDC155 (Two-hybrid), NAALADL2 (Two-hybrid), GPR25 (Two-hybrid), GPR25 (Two-hybrid), GPR25 (Two-hybrid), GPR25 (Two-hybrid), GPR25 (Two-hybrid), GPR25 (Two-hybrid), GPR25 (Two-hybrid), GPR25 (Two-hybrid)
ESM2 similar proteins: A0A6I8PUB9, O00155, O00270, O14842, O14843, O15529, O43603, O46685, O60755, O88626, O88634, O88853, O88854, O88855, P0C5I1, P46092, P46093, P50132, Q149R9, Q15722, Q15743, Q1JQB3, Q3T181, Q3UFD7, Q3ZC80, Q4KLH9, Q6XKD3, Q76JU8, Q76JU9, Q76JV1, Q86VZ1, Q8BUD0, Q8BYC4, Q8HYC3, Q8K3T4, Q8TDS5, Q8TDU9, Q920E0, Q924U0, Q96G91
Diamond homologs: A0A287A2K5, C8YUV0, O00155, O02836, O08786, O15973, O18935, O19012, O19014, O19025, O19032, O19054, O19091, O62729, O77408, O77700, O77721, O77830, O97665, O97772, P04761, P08482, P0C5I1, P11229, P12657, P17200, P18089, P19328, P22270, P25021, P30545, P30551, P30552, P30553, P30796, P32211, P32238, P32239, P32302, P46627
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| GPR25 | “up-regulates activity” | GNAI1 | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 33 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Transport of small molecules | 5 | 6.6× | 7e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
45 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 43 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
66 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:200873846:C:T | donor_gain | 0.5500 |
| 1:200873789:GCAC:G | donor_gain | 0.5400 |
| 1:200873790:C:T | donor_gain | 0.5100 |
| 1:200873150:GC:G | donor_gain | 0.4900 |
| 1:200873477:C:T | donor_gain | 0.4800 |
| 1:200873792:C:G | donor_gain | 0.4800 |
| 1:200873739:C:G | donor_gain | 0.4600 |
| 1:200873681:T:TA | acceptor_gain | 0.4500 |
| 1:200873743:G:A | donor_gain | 0.4500 |
| 1:200873795:T:A | donor_gain | 0.4400 |
| 1:200873684:T:TA | donor_gain | 0.4300 |
| 1:200873757:G:GT | donor_gain | 0.4200 |
| 1:200873966:T:A | acceptor_gain | 0.4000 |
| 1:200873793:G:GG | donor_gain | 0.3900 |
| 1:200873764:C:G | donor_gain | 0.3800 |
| 1:200873151:C:G | donor_gain | 0.3700 |
| 1:200873786:A:T | donor_gain | 0.3700 |
| 1:200873937:C:G | donor_gain | 0.3600 |
| 1:200873462:TG:T | donor_gain | 0.3500 |
| 1:200873711:T:G | acceptor_gain | 0.3500 |
| 1:200873740:G:GG | donor_gain | 0.3500 |
| 1:200873707:C:A | acceptor_gain | 0.3400 |
| 1:200873754:G:GT | donor_gain | 0.3400 |
| 1:200873698:T:TA | acceptor_gain | 0.3300 |
| 1:200873796:T:A | donor_gain | 0.3300 |
| 1:200873935:A:AG | acceptor_gain | 0.3300 |
| 1:200873936:G:GG | acceptor_gain | 0.3300 |
| 1:200873936:GCTGC:G | acceptor_gain | 0.3300 |
| 1:200873936:GCT:G | acceptor_gain | 0.3200 |
| 1:200873704:T:A | acceptor_gain | 0.3000 |
AlphaMissense
2229 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:200873352:G:C | W105C | 0.996 |
| 1:200873352:G:T | W105C | 0.996 |
| 1:200873437:A:C | S134R | 0.992 |
| 1:200873439:C:A | S134R | 0.992 |
| 1:200873439:C:G | S134R | 0.992 |
| 1:200873794:T:C | F253L | 0.992 |
| 1:200873796:T:A | F253L | 0.992 |
| 1:200873796:T:G | F253L | 0.992 |
| 1:200873380:A:C | S115R | 0.991 |
| 1:200873382:C:A | S115R | 0.991 |
| 1:200873382:C:G | S115R | 0.991 |
| 1:200873371:T:A | C112S | 0.989 |
| 1:200873372:G:C | C112S | 0.989 |
| 1:200873935:A:C | S300R | 0.989 |
| 1:200873937:C:A | S300R | 0.989 |
| 1:200873937:C:G | S300R | 0.989 |
| 1:200873315:C:A | P93Q | 0.987 |
| 1:200873350:T:A | W105R | 0.987 |
| 1:200873350:T:C | W105R | 0.987 |
| 1:200873926:T:C | F297L | 0.987 |
| 1:200873928:C:A | F297L | 0.987 |
| 1:200873928:C:G | F297L | 0.987 |
| 1:200873208:C:A | N57K | 0.986 |
| 1:200873208:C:G | N57K | 0.986 |
| 1:200873315:C:G | P93R | 0.986 |
| 1:200873194:G:C | G53R | 0.985 |
| 1:200873372:G:A | C112Y | 0.985 |
| 1:200873813:C:G | P259R | 0.984 |
| 1:200873291:A:T | D85V | 0.983 |
| 1:200873527:T:A | W164R | 0.983 |
dbSNP variants (sampled 300 via entrez): RS1000116139 (1:200871958 C>T), RS1000420389 (1:200872330 T>G), RS1001731879 (1:200871404 A>G), RS1003585136 (1:200874479 C>A), RS1004056585 (1:200871146 C>T), RS1004318049 (1:200872678 G>A,C,T), RS1005010378 (1:200871142 C>T), RS1005678983 (1:200872518 C>G,T), RS1005729916 (1:200872847 C>T), RS1008409196 (1:200874183 G>A,C), RS1008570637 (1:200874417 G>A), RS1009108030 (1:200872460 C>T), RS1011230496 (1:200873880 G>A,C), RS1012857043 (1:200873133 C>T), RS1013196068 (1:200873457 C>G,T)
Disease associations
OMIM: gene MIM:602174 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005529_17 | Ankylosing spondylitis | 7.000000e-16 |
| GCST005529_35 | Ankylosing spondylitis | 2.000000e-15 |
| GCST010002_373 | Refractive error | 1.000000e-52 |
| GCST010571_8 | Autoimmune thyroid disease | 3.000000e-09 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL4523858 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: gpcr — Class A Orphans with emerging pharmacology
CTD chemical–gene interactions
15 total (human), top 15 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | decreases expression, increases abundance, increases expression | 2 |
| Particulate Matter | decreases expression, increases abundance, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| butyraldehyde | increases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Carmustine | decreases expression | 1 |
| Lipopolysaccharides | increases expression, affects response to substance | 1 |
| Valproic Acid | increases methylation | 1 |
| p-Chloromercuribenzoic Acid | increases expression | 1 |
ChEMBL screening assays
2 unique, capped per target: 2 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL4883441 | Binding | PRESTO-Tango GPCRome screening (GPR25) | Data for DCP probe UCSF924 |
Cellosaurus cell lines
1 cell lines: 1 spontaneously immortalized cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_KX52 | PathHunter CHO-K1 GPR25 beta-arrestin | Spontaneously immortalized cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.